Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
The increase is thought to be related to environmental factors.
Combining 2 predictors yielded better results than just using 1.
The investigators observed significantly higher postoperative CTC counts in the open radical nephrectomy group compared with the other 3 groups in the study.
If the vaccine is shown to work, it may help delay the use of ADT in such patients, Dr Maeng said.